France – Medicinal products for the blood and blood-forming organs – UNIHA Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie Génique
Opportunity Score
Confidence: 30%
Complexity: medium
1142 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This tender by Hospices Civils de Lyon (France) establishes a Dynamic Purchasing System (DPS) and framework agreement for blood-derived, recombinant, and gene therapy medicinal products. It covers a single lot with a 45-month duration. The deadline for submission is 31 July 2029. No estimated value is provided. Submission is electronic and must be in French. Selection criteria are vaguely defined as 'Critères Divers' (various criteria). Award criteria are absent from the provided data. The tender is open to SMEs and involves no EU funding.
Strengths
Documents available
Open procedure
Medium complexity
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Electronic submission via www.marches-publics.gouv.fr.
- Tenders must be submitted in French.
- Must comply with Directive 2014/24/EU.
Buyer
Name
Hospices Civils de Lyon
Location
Lyon Cedex 08, FRA
Website
Buyer profile
Identifier
26690027300019
Lots (1)
Dynamic acquisition system for blood-derived medicinal products, including recombinant and gene therapy products, managed by the groupement de commandes Uni.H.A. Place of performance is France.
Procurement Details
Publication
18 Nov 2025
Deadline
31 Jul 2029, 12:00
Procedure
open
Contract
supplies
Duration
45 MONTH
Language
FRA
Publication #
766772-2025
Classification
Performance: France
Documents (2)
Opportunity Score
Confidence: 30%
Complexity: medium
1142 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation